A large proportion of patients in this study exhibited indications of advanced and/or aggressive prostate cancer, as suggested by markedly elevated mean and median PSA levels and a high frequency of histopathologic parameters associated with aggressive disease. The gene discussed is KLK3; the disease is prostate carcinoma.